Advertisement

Topics

Latest "Seattle Biomedical Research Institute" News Stories

05:18 EST 15th December 2017 | BioPortfolio

Here are the most relevant search results for "Seattle Biomedical Research Institute" found in our extensive news archives from over 250 global news sources.

More Information about Seattle Biomedical Research Institute on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Seattle Biomedical Research Institute for you to read. Along with our medical data and news we also list Seattle Biomedical Research Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seattle Biomedical Research Institute Companies for you to search.

Showing "Seattle Biomedical Research Institute" News Articles 1–25 of 31,000+

Extremely Relevant

Promising new drug for Hep B tested at Texas Biomedical Research Institute

(Texas Biomedical Research Institute) Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.


#jobs #lifescience San Diego Biomedical Research Institute: Principal Investigator / Faculty

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: San Diego Biomedical Research Institute: Principal Investigator / Faculty . Salary is commensurate with level of position.: San Diego Biomedical Research Institute: San Diego Biomedical Research Institute (SDBRI) … Continue reading → Cet article #jobs #lifescience ...

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.


Relevant

Texas Biomedical Research Institute Tests Promising New Drug for Hepatitis B

Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. Testing at SNPRC provided proof this novel therapeutic approach and drug delivery mechanism would be safe and effective, as

Search for novel biomarkers indicating early cardiovascular disease risk wins funding

(Texas Biomedical Research Institute) Texas Biomedical Research Institute scientists have been granted funding from the National Institutes of Health to pursue a promising study on the ultimate causes of heart disease and metabolic disorders.

Researchers receive $11.5 million program project grant to eliminate drug resistant malaria

Texas Biomedical Research Institute researchers, Dr. Tim Anderson and Dr. Ian Cheeseman, have partnered with researchers at the University of Notre Dame and the Center for Infectious Disease Research in Seattle to pursue studies in drug resistant malaria.

New model for Zika developed to aid in testing vaccines and treatments

(Texas Biomedical Research Institute) An alternative animal model that mimics key features of the Zika virus infection, including its lingering presence in bodily fluids, has been developed at Texas Biomedical Research Institute in San Antonio.

$11.5 million program project aims to combat malaria drug resistance

(Texas Biomedical Research Institute) Texas Biomed researchers have partnered with researchers at Notre Dame and the CIDR in Seattle to pursue studies in drug resistant malaria.

Zhejiang Hisun Partners with Seattle's IDRI on Treatment for Drug-Resistant TB

Zhejiang Hisun Pharma will provide clinical trial supplies of a novel inhaled treatment for drug resistant TB for Seattle's IDRI (Infectious Disease Research Institute). The agreement, described as a partnership, will presumably include commercial supply, though details were not disclosed. CPZEN-45 was originally discovered by the Institute of Microbial Chemistry (IMC), a nonprofit Tokyo research ...

New key regulator of acquisition of immune tolerance to tumor cells in cancer patients

(IDIBELL-Bellvitge Biomedical Research Institute) Researchers of the Chromatin and Disease Group from the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona have identified a distinctive epigenetic event in immune cells that differentiate in the tumoral microenvironment and make them tolerant to cancer cells.

Shaun Coughlin from UCSF Cardiovascular Research Center to cardio group for the Novartis Institute for Biomedical Research in Cambridge, MA

Shaun Coughlin from UCSF Cardiovascular Research Center to cardio group for the Novartis Institute for Biomedical Research in Cambridge, MA Reporter: Aviva Lev-Ari, PhD, RN   The dean of the UCSF med school, Talmadge King, had this to say in his sendoff today: Coughlin’s “research discoveries revealed a mechanism by which proteases regulate cellular behaviors […]

Casebia and Seattle Children's study gene-edited regulatory T-cell therapies

Casebia Therapeutics joined forces with Seattle Children’s Research Institute to research and develop autoimmune disease tr...

TX Biomed part of team on 5-year, $4.4 million NIH grant for novel TB vaccine testing

(Texas Biomedical Research Institute) Texas Biomedical Research Institute Associate Scientist Dr. Marie-Claire Gauduin has partnered with Dr. Chinnaswamy Jagannath, professor at McGovern Medical School at UTHealth in Houston to test a modified TB vaccine that, if effective, could prove more powerful and provide longer lasting immunity. Dr. Gauduin and Dr. Jagannath are principal investigators on t...

New Seattle precision medicine institute will catalog 60K breast cancer gene mutations

Body:  A $50 million donation by Jeffrey and Susan Brotman and Pam and Dan Baty will help create the Brotman Baty Institute for Precision Medicine, according to a recent University of Washington news release. The institute will combine the expertise of UW Medicine, Fred Hutchinson Cancer Research Center in Seattle and Seattle Children's Hospital.  According to the r

Can GSK and Altius reshape the way drug development is conducted?

Lon Cardon, GSK, and John Stamatoyannopoulos, University of Washington, discuss the recent launch of Altius Institute for Biomedical Sciences. Funded by GSK, Altius is an independent non-profit research institute focused on genomic research.

Large-scale approach reveals imperfect actor in plant biotechnology

(Whitehead Institute for Biomedical Research) A research team led by Whitehead Institute has unraveled the molecular activities of a key protein that can enable plants to withstand a common herbicide. Their findings reveal how the protein can sometimes act imprecisely, and how it can be successfully re-engineered to be more precise.

Casebia Therapeutics Announces License And Collaboration Agreements With Seattle Children's Research Institute

  Life Sciences Jobs   ...

Infectious Disease Research Institute (IDRI) Release: Promising New Leprosy Vaccine Moves Into Human Trials

SEATTLE and GREENVILLE, S.C., Oct. 12, 2017 /PRNewswire-USNewswire/ --Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial...

Personalized Lifestyle Medicine Conference Brings Healthcare Professionals to Seattle in October

SEATTLE, Oct. 10, 2017 /PRNewswire/ -- The Personalized Lifestyle Medicine Institute (PLMI) will host the Fifth Annual Thought Leaders Consortium this month. This program has attracted international attention and is now sold out. Several hundred health care professionals, research scientists, business leaders, and tech innovators will gather at the Hyatt Regency Lake Washington Oct. 13-14, 20...

UNH receives NIH grant to advance its biomedical research to the bedside

(University of New Hampshire) The University of New Hampshire has been awarded a five-year, $10 million National Institutes of Health Center of Biomedical Research Excellence grant to accelerate the translation of its basic biomedical and bioengineering research.

Time to end the federal ban on gun violence research funding

In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may...

Discussing Open Science with the Head of Translation at The Francis Crick Institute

Officially opened less than a year ago, The Francis Crick Institute is already conducting top-level biomedical research, has launched two spin-outs and struck research partnerships with both AstraZeneca and GlaxoSmithKline. I spoke to the Head of Translation, Dr. Véronique Birault, ... This awesome article Discussing Open Science with the Head of Translation at The Francis Crick Institute appeare...

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

(Seattle Children's) Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants.

Port of Seattle works to lower environmental impact

The Port of Seattle, which operates Seattle-Tacoma International Airport, contends that climate change will continue to affec -More- 

Kymab And Seattle Children's Research Institute Publish Impressive Results Using KY1005 In A Model Of Acute Graft Versus Host Disease (Agvhd) In Science Translational Medicine

  Life Sciences Jobs   ...


Quick Search
Advertisement
 

News Quicklinks